NCT02313545View on ClinicalTrials.gov

Phase I-B Study to Evaluate the Safety, Tolerability and Efficacy of IZN-6NVS for the Treatment of AV and DIV

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

December 31, 2016

Study Completion Date

March 31, 2017

Conditions

Atrophic Vaginitis

Interventions

DRUG

IZN-6NVS Cream

"IZN-6NVS, a hydrocream containing three herbal extracts, is a polymolecular agent derived from botanical sources. It is composed of a blend of three herbal extracts, Centella asiatica, Echinacea purpurea, and Sambucus nigra.~Cream concentration: 5%"

Trial Locations (3)

10469

Eastchester Medical Associates, The Bronx

98105

Seattle Women's, Seattle

Unknown

Shaare Zedek Medical Center, Jerusalem